HIV Infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease

Journal of Infectious Diseases

Volumn 199, Issue 7, 2009, Pages 1007-1018

  Fontaine, Julie ^a,c   Coutlée, François ^b,c   Tremblay, Cécile ^c   Routy, Jean Pierre ^d   Poudrier, Johanne ^a,c   Roger, Michel ^a,c,e  

^a Laboratoire d'Immunogénétique   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BONE MARROW CELL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS LOAD; BLOOD; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYELOID CELLS; VIRAL LOAD;

EID: 65549123647     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597278     Document Type: Article

References (49)

1. Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, Steinman RM. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4-T cells. Science 1992; 257:383-7.
2. Pope M, Betjes MG, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994; 78:389-98.
3. Cimarelli A, Zambruno G, Marconi A, Girolomoni G, Bertazzoni U, Giannetti A. Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr 1994; 7:230-5.
4. Frankel SS, Wenig BM, Burke AP, et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996; 272:115-7.
5. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990; 71:38-45.
6. Rinfret A, Latendresse H, Lefebvre R, St-Louis G, Jolicoeur P, Lamarre L. Human immunodeficiency virus-infected multinucleated histiocytes in oropharyngeal lymphoid tissues from two asymptomatic patients. Am J Pathol 1991; 138:421-6.
7. Granelli-Piperno A, Delgado E, Finkel V, Paxton W, Steinman RM. Immature dendritic cells selectively replicate macrophagetropic (Mtropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M-and T-tropic virus to T cells. J Virol 1998; 72: 2733-7.
8. Granelli-Piperno A, Shimeliovich I, Pack M, Trumpfheller C, Steinman RM. HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J Immunol 2006; 176:991-8.
9. Chehimi J, Campbell DE, Azzoni L, et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002; 168:4796-801.
10. Donaghy H, Pozniak A, Gazzard B, et al. Loss of blood CD11c-myeloid and CD11c-plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001; 98:2574-6.
11. Müller H, Weier S, Kojouharoff G, et al. Distribution and infection of Langerhans cells in the skin of HIV-infected healthy subjects and AIDS patients. Res Virol 1993; 144:59-67.
12. Spörri B, von Overbeck J, Brand CU, et al. Reduced number of Langerhans cells in oral mucosal washings from HIV-1 seropositives. J Oral Pathol Med 1994; 23:399-402.
13. Biancotto A, Grivel J-C, Iglehart SJ, et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007; 109:4272-9.
14. McIlroy D, Autran B, Clauvel JP, Oksenhendler E, Debré P, Hosmalin A. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV-patients. AIDS Res Hum Retroviruses 1998; 14:505-13.
15. Eales LJ, Farrant J, Helbert M, Pinching AJ. Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function. Clin Exp Immunol 1988; 71:423-7.
16. Pimpinelli N, Borgognoni L, Riccardi R, et al. CD36(OKM5)-dendritic cells in the oral mucosa of HIV-and HIV- subjects. J Invest Dermatol 1991; 97:537-42.
17. Loré K, Sönnerborg A, Broström C, et al. Accumulation of DCSIGN -CD40-dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 2002; 16:683-92.
18. Colonna M, Trinchieri G, Liu Y-J. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5:1219-26.
19. Patterson S, Rae A, Hockey N, Gilmour J, Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol 2001; 75:6710-3.
20. Beignon AS, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115:3265-75.
21. Groot F, van Capel TMM, Kapsenberg ML, Berkhout B, de Jong EC. Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood 2006; 108:1957-64.
22. Kamga I, Kahi S, Develioglu L, et al. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J Infect Dis 2005; 192:303-10.
23. Donaghy H, Gazzard B, Gotch F, Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003; 101:4505-11.
24. Mercier F, Boulassel MR, Yassine-Diab B, et al. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4-and CD8-T cell subsets. Clin Exp Immunol 2008; 152:72-80.
25. Piccioli D, Tavarini S, Borgogni E, et al. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 2007; 109:5371-9.
26. Ho CSK, Munster D, Pyke CM, Hart DNJ, Lopez JA. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002; 99:2897-904.
27. Shi J, Iked K, Maeda Y, et al. Identification of CD123- myeloid dendritic cells as an early-stage immature subset with strong tumoristatic potential. Cancer Lett 2008; 270:19-29.
28. Poudrier J, Weng X, Kay DG, et al. The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6. Immunity 2001; 15:173-85.
29. Dillon SM, Robertson KB, Pan SC, et al. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 2008; 48:1-12.
30. Ancuta P, Weiss L, Haeffner-Cavaillon N. CD14-CD16 cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol 2000; 30: 1872-83.
31. Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schakel K. The CD16- (Fc gamma RIII-) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002; 196:517-27.
32. Abelian A, Burling K, Easterbrook P, Winter G. Hyperimmunoglobulinemia and rate of HIV type 1 infection progression. AIDS Res Hum Retroviruses 2004; 20:127-8.
33. Jacobson MA, Khayam-Bashi H, Martin JN, Black D, Ng V. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr 2002; 31:472-7.
34. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active anti-retroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 2005; 35:166-74.
35. Bekker V, Scherpbier H, Pajkrt D, Jurriaans S, Zaaijer H, Kuijpers TW. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 2006; 118:e315-22.
36. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006; 108:3786-91.
37. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986; 233:1084-6.
38. Monroe JG, Silberstein LE. HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol 1995; 15:61-8.
39. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004; 2:11-21.
40. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107:3034-44.
41. Titanji K, De Milito A, Cagigi A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-7.
42. Cerutti A, Qiao X, He B. Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching. Immunol Cell Biol 2005; 83:554-62.
43. Poudrier J, Weng X, Kay DG, Hanna Z, Jolicoeur P. The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells. J Virol 2003; 77:11733-44.
44. Messmer D, Jacque J-M, Santisteban C, et al. Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells. J Immunol 2002; 169:4172-82.
45. Almeida M, Cordero M, Almeida J, Orfao A. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 2005; 19:261-71.
46. Chehimi J, Azzoni L, Farabaugh M, et al. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment. J Immunol 2007; 179:2642-50.
47. Meyers JH, Justement JS, Hallahan CW, et al. Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells. PLoS ONE 2007; 2:e458.
48. Hardy AW, Graham DR, Shearer GM, Herbeuval JP. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-. Proc Natl Acad Sci USA 2007; 104:17453-8.
49. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-5.